Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 28, 2017; 23(12): 2217-2222
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2217
Table 1 Demographic and clinical features of patients identified with pancreatitis based on imaging criteria
AP (n = 13)RAP (n = 65)CP (n = 116)P value
Age (yr) (mean ± SD)29.8 ± 11.629.0 ± 11.533.3 ± 14.20.10
Male: female12 : 157 : 896 : 200.53
Alcoholic pancreatitis2 (15.4)19 (29.2)28 (24.1)0.10
(≥ 50 g/d)
Idiopathic pancreatitis11 (84.6)46 (70.8)88 (75.9)0.52
Duration of symptoms (in months) [median (interquartile range)]0 (0-0.2)7.0 (3.5-24.0)24.0 (4.0-48.0)< 0.001
VAS (mean ± SD)5.4 ± 2.06.4 ± 2.315.4 ± 2.50.02
Table 2 Stool fat in grams/day by acid steatocrit in M-ANNHEIM stages of pancreatitis
M-ANNHEIM stage (n %)Median (IQ range) of stool fat in g/d
0, 13 (6.7)6.3 (6.0-6.6)
I, 87 (44.8)6.3 (5.9-6.4)
II, 89 (45.8)7.5 (6.4-10.8)
III, 5 (2.5)15.3 (12.0-15.6)
Table 3 Faecal elastase-1 levels in M-ANNHEIM stages of pancreatitis
M-ANNHEIM stage (n %)Median (IQ range) of stool fat in g/d
0, 13 (6.7)289.0 (249.0-383.2)
I, 85 (43.8)389.1 (263.2-436.1)
II, 75 (38.6)144.3 (108.9-219.0)
III, 21 (10.8)87.6 (41.1-119.1)
Table 4 Comparing the number of patients based on M-ANNHEIM staging by acid steatocrit and faecal elastase-1 estimations n (%)
M-ANNHEIM stagesAcid steatocrit methodFE-1 test
013 (06.7)13 (06.7)
I87 (44.8)85 (43.8)
II89 (45.8)75 (38.6)
III05 (2.5)21 (10.8)